Journal of Viral Hepatitis

Expert opinion on the treatment of patients with chronic hepatitis C
pp. 75-90(16)
Authors: Zeuzem, S.; Berg, T.; Moeller, B.; Hinrichsen, H.; Mauss, S.; Wedemeyer, H.; Sarrazin, C.; Hueppe, D.; Zehnter, E.; Manns, M. P.

Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection
pp. 91-93(3)
Authors: Chotiyaputta, W.; Lok, A. S.

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study
pp. 94-103(10)
Authors: Xu, W.-M.; Cui, Y.-T.; Wang, L.; Yang, H.; Liang, Z.-Q.; Li, X.-M.; Zhang, S.-L.; Qiao, F.-Y.; Campbell, F.; Chang, C.-N.; Gardner, S.; Atkins, M.

Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients
pp. 104-112(9)
Authors: Lu, L.; Zhang, H.-Y.; Yueng, Y.-H.; Cheung, K.-F.; Luk, J. M.; Wang, F.-S.; Lau, G. K. K.

On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks
pp. 113-120(8)
Authors: Reijnders, J. G. P.; Leemans, W. F.; Hansen, B. E.; Pas, S. D.; de Man, R. A.; Schutten, M.; Janssen, H. L. A.

FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study
pp. 121-131(11)
Authors: Foucher, J.; Reiller, B.; Jullien, V.; Léal, F.; di Cesare, E. S.; Merrouche, W.; Delile, J.-M.; de Lédinghen, V.

Changes of non-invasive markers and FibroScan values during HCV treatment
pp. 132-140(9)
Authors: Vergniol, J.; Foucher, J.; Castéra, L.; Bernard, P.-H.; Tournan, R.; Terrebonne, E.; Chanteloup, E.; Merrouche, W.; Couzigou, P.; de Lédinghen, V.

Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection
pp. 141-148(8)
Authors: Gonzalez, S. A.; Fiel, M. I.; Sauk, J.; Canchis, P. W.; Liu, R.-C.; Chiriboga, L.; Yee, H. T.; Jacobson, I. M.; Talal, A. H.